Wang Xun

[Expert Profile] Wang Xun, Chief Physician, Professor, Doctoral Supervisor, is a renowned expert in neurogenetics and pediatric neurological diseases in China, working in the Department of Neurology, The First Affiliated Hospital of Anhui Medical University. He has long been dedicated to the clinical diagnosis, treatment, and basic research of tuberous sclerosis, leukodystrophy, adrenoleukodystrophy, and other difficult neurological diseases.

[Education & Career] Professor Wang Xun graduated from Anhui Medical University, has been deeply involved in the field of neurology for decades, and has long been engaged in clinical and research work on difficult neurological diseases, genetic disorders, and pediatric neurological conditions. He has held important positions in relevant societies such as the Neurology Branch of the Anhui Medical Association, and has presided over projects including the National Natural Science Foundation of China and major Anhui provincial research programs. He has accumulated extensive experience in rare diseases such as tuberous sclerosis and leukodystrophy, and is a discipline backbone in the field of neurology in Anhui Province.

[Areas of Expertise] Professor Wang specializes in comprehensive evaluation and targeted therapy for tuberous sclerosis complex (TSC), the diagnosis and long-term management of hereditary leukoencephalopathies such as leukodystrophy and adrenoleukodystrophy, and the diagnosis and treatment of various difficult hereditary neurological diseases in both children and adults. He has extensive experience in genetic testing interpretation, multi-system involvement assessment, and multidisciplinary collaborative management. He excels at coordinating neurology, dermatology, nephrology, cardiology, and other multidisciplinary teams to provide one-stop comprehensive diagnosis and treatment plans for patients with rare genetic diseases.

[Academic Achievements & Industry Contributions] Professor Wang has conducted a series of clinical studies in the fields of tuberous sclerosis and hereditary leukoencephalopathies, systematically summarizing the clinical features, imaging manifestations, and genotype-phenotype correlations of these rare diseases, with findings published in domestic and international neurology journals. He has actively participated in the standardized development of rare disease diagnosis and treatment in China, promoted the standardized application of genetic testing and targeted drugs (such as mTOR inhibitors) in tuberous sclerosis, and organized grassroots physician training and rare disease free clinics, significantly improving the recognition and diagnosis level of rare genetic diseases in the region, and making positive contributions to early diagnosis and treatment of rare disease patients.

[Clinical Practice & Outstanding Contributions] For decades on the clinical front lines, Professor Wang has cumulatively treated thousands of patients with rare diseases such as tuberous sclerosis and leukodystrophy, including many who were misdiagnosed after traveling to multiple hospitals. He is especially dedicated to rare disease patients, insisting on long-term follow-up and whole-course care, providing continuous support from diagnosis through treatment and rehabilitation for patients and their families. He has repeatedly traveled to grassroots hospitals to provide technical assistance and science popularization lectures. He is a neurogenetics expert trusted by patients and recognized by colleagues alike.

[Honors & Reputation] Professor Wang Xun has long held relevant academic positions in the Chinese Association Against Epilepsy, and has presided over projects including the National Natural Science Foundation of China and provincial and ministerial research programs. He is a senior expert in the field of rare neurological diseases in China. He has accumulated extensive experience in the clinical diagnosis, imaging, and pathological evaluation of difficult rare diseases such as tuberous sclerosis, leukodystrophy, and adrenoleukodystrophy. He has led the establishment of a multidisciplinary collaborative diagnosis and treatment team for rare neurological diseases, promoted the standardized clinical application of genetic testing, imaging follow-up, and whole-course management, and participated in the development of multiple Chinese diagnostic standards for neurological rare diseases. He has long been deeply involved in grassroots consultation and science popularization, helping numerous rare disease patients and their families receive scientific diagnosis, treatment, and care support, and is deeply trusted by patients.